Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alkaline Phosphatase, Placental-Like 2 (ALPPL2) is a membrane-bound glycosylated enzyme that belongs to the alkaline phosphatase family. It catalyzes the hydrolysis of phosphate esters. ALPPL2 is primarily localized in the testis, thymus, and certain germ cell tumors. It is closely related to intestinal and placental alkaline phosphatases. While placental alkaline phosphatase (PLAP) is a well-known tumor marker, ALPPL2 is also expressed in some testicular germ cell tumors and may serve as a marker for these malignancies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alkaline Phosphatase, Placental-Like 2 (ALPPL2).